TrialJAMA2017

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Alan P Venook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.